Govt Mandates Barcodes on Key Drug Categories to Curb Counterfeits

In decisive move to fight the growing threat of counterfeit medicines, the Indian government has changed the Drugs Rules, 1945 to require barcodes or QR codes to be required on the packaging of certain high-risk medications...

Karnataka Govt Unveils 3-Year Plan to Strengthen Advanced Healthcare Access

The Karnataka government has declared a grand three-year program to revamp the state's healthcare network by setting up super-specialty hospitals, trauma centres, and cancer treatment units in all 31 districts of the state.

AstraZeneca Expands Bengaluru Hub to Boost AI and R&D Innovation

AstraZeneca, a biopharmaceutical company, announced on Thursday that it had invested Rs 166 crore to expand its global center in Bengaluru, adding 400 positions to support AI innovation, global services, and research & development.

India's First TREAT Program for Kidney Transplant Launched by Fortis

In yet another clinical milestone, Fortis Hospital, Bannerghatta Road, Bengaluru has advanced its robot-aided infrastructure with the launch of the TREAT program

Lupin Launches Prucalopride Tablets to Expand GI Drug Portfolio

Lupin Ltd, the world's largest Indian pharma company, has declared US commercial availability of Prucalopride tablets with strengths of 1 mg and 2 mg.

Aurobindo's CuraTeQ Gets UK MHRA Nod for Biosimilar Dyrupeg

Hyderabad-based Aurobindo Pharma has made a milestone in its biosimilar growth plans, when its subsidiary CuraTeQ Biologics s.r.o. received clearance by the UK's Medicines and Healthcare products Regulatory Agency

Pharmexcil Appoints Advisors to Strengthen Export Regulatory Support

Pharmaceuticals Export Promotion Council of India (Pharmexcil) has assigned two honorary advisors to provide assistance to export pharmaceutical producers with regulatory issues surrounding Foreign Trade Policy (FTP) permitting and other matters...

Lupin Secures FDA Approval for Prucalopride Constipation Drug

Lupin Limited, a multinational pharmaceutical company based in Mumbai, informed that it has received final approval from the US FDA for its Abbreviated New Drug Application (ANDA) on Prucalopride Tablets 1 mg and 2 mg.

Dr Lal PathLabs Scales Genomics with Illumina's NovaSeq X

Dr Lal PathLabs has enhanced its genomic capabilities by acquiring Illumina's NovaSeq X Series to the dedicated genomics division Genevolve. This additional technology expands the lab's ability to provide rapid and reliable genomic information for...

Government Launches Rs 5000 Crore Scheme to Boost Pharma Innovation

The Department of Pharmaceuticals will be supporting the research and innovation in pharma and medical technology, as the department has released an online portal for a scheme of Rs.5,000 crore. India is one of the major pharmaceutical m...

on the deck

Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.